- Home
- EXEL vs UHS Comparison
EXEL vs UHS Comparison
Compare EXEL & UHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- UHS
- Stock Information
- Founded
- EXEL 1994
- UHS 1978
- Country
- EXEL United States
- UHS United States
- Employees
- EXEL N/A
- UHS N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- UHS Hospital/Nursing Management
- Sector
- EXEL Health Care
- UHS Health Care
- Exchange
- EXEL Nasdaq
- UHS Nasdaq
- Market Cap
- EXEL 9.8B
- UHS 11.7B
- IPO Year
- EXEL 2000
- UHS N/A
- Fundamental
- Price
- EXEL $36.17
- UHS $181.75
- Analyst Decision
- EXEL Buy
- UHS Buy
- Analyst Count
- EXEL 18
- UHS 17
- Target Price
- EXEL $37.59
- UHS $222.31
- AVG Volume (30 Days)
- EXEL 2.2M
- UHS 846.0K
- Earning Date
- EXEL 05-13-2025
- UHS 04-28-2025
- Dividend Yield
- EXEL N/A
- UHS 0.44%
- EPS Growth
- EXEL 170.77
- UHS 51.30
- EPS
- EXEL 1.76
- UHS 17.80
- Revenue
- EXEL $2,168,701,000.00
- UHS $16,084,073,000.00
- Revenue This Year
- EXEL $5.78
- UHS $9.55
- Revenue Next Year
- EXEL $10.94
- UHS $5.42
- P/E Ratio
- EXEL $20.64
- UHS $10.22
- Revenue Growth
- EXEL 18.50
- UHS 9.73
- 52 Week Low
- EXEL $20.14
- UHS $153.99
- 52 Week High
- EXEL $40.26
- UHS $243.25
- Technical
- Relative Strength Index (RSI)
- EXEL 43.89
- UHS 54.48
- Support Level
- EXEL $34.90
- UHS $175.41
- Resistance Level
- EXEL $40.26
- UHS $187.98
- Average True Range (ATR)
- EXEL 1.21
- UHS 5.90
- MACD
- EXEL -0.19
- UHS 1.58
- Stochastic Oscillator
- EXEL 23.69
- UHS 79.49
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About UHS Universal Health Services Inc.
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.